Dimensional Fund Advisors LP Novo Cure LTD Transaction History

Dimensional Fund Advisors LP

$391 Billion
Q1 2025

A detailed history of Dimensional Fund Advisors LP transactions in Novo Cure LTD stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 25,307 shares of NVCR stock, worth $485,388. This represents 0.0% of its overall portfolio holdings.

Number of Shares

25,307

Previous 25,753 1.73%

Holding current value

$485,388

Previous $767,000 41.33%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$17.82 - $30.19 $7,947 - $13,464	-446 Reduced 1.73%	25,307 $450,000
Q4 2024 Feb 13, 2025	SELL	$14.54 - $33.41 $43,852 - $100,764	-3,016 Reduced 10.48%	25,753 $767,000
Q3 2024 Nov 07, 2024	SELL	$15.61 - $23.34 $13,970 - $20,889	-895 Reduced 3.02%	28,769 $449,000
Q2 2024 Aug 09, 2024	SELL	$11.83 - $24.05 $9,286 - $18,879	-785 Reduced 2.58%	29,664 $508,000
Q1 2024 May 10, 2024	SELL	$12.42 - $17.29 $83,984 - $116,914	-6,762 Reduced 18.17%	30,449 $475,000
Q4 2023 Feb 07, 2024	BUY	$11.13 - $15.78 $27,146 - $38,487	2,439 Added 7.01%	37,211 $555,000
Q3 2023 Nov 09, 2023	SELL	$16.15 - $42.35 $1.09 Million - $2.87 Million	-67,795 Reduced 66.1%	34,772 $561,000
Q2 2023 Aug 09, 2023	SELL	$40.29 - $82.51 $3.03 Million - $6.21 Million	-75,264 Reduced 42.32%	102,567 $4.26 Million
Q1 2023 May 12, 2023	BUY	$56.44 - $118.81 $730,785 - $1.54 Million	12,948 Added 7.85%	177,831 $10.7 Million
Q4 2022 Feb 09, 2023	BUY	$63.98 - $85.37 $162,701 - $217,095	2,543 Added 1.57%	164,883 $12.1 Million
Q3 2022 Nov 10, 2022	BUY	$67.99 - $89.57 $1.23 Million - $1.63 Million	18,148 Added 12.59%	162,340 $12.3 Million
Q2 2022 Aug 12, 2022	BUY	$56.6 - $89.9 $948,559 - $1.51 Million	16,759 Added 13.15%	144,192 $10 Million
Q1 2022 May 13, 2022	BUY	$60.15 - $84.52 $152,420 - $214,173	2,534 Added 2.03%	127,433 $10.6 Million
Q4 2021 Feb 09, 2022	BUY	$75.08 - $121.99 $207,220 - $336,692	2,760 Added 2.26%	124,899 $9.38 Million
Q3 2021 Nov 12, 2021	SELL	$116.17 - $194.55 $116,518 - $195,133	-1,003 Reduced 0.81%	122,139 $14.2 Million
Q2 2021 Aug 12, 2021	SELL	$130.4 - $225.58 $4.83 Million - $8.36 Million	-37,052 Reduced 23.13%	123,142 $27.3 Million
Q1 2021 May 14, 2021	SELL	$124.11 - $190.17 $511,333 - $783,500	-4,120 Reduced 2.51%	160,194 $21.2 Million
Q4 2020 Feb 25, 2021	BUY	$112.16 - $174.14 $18.4 Million - $28.6 Million	164,314 New	164,314 $28.4 Million

Others Institutions Holding NVCR

# of Institutions

266

Shares Held

79.4M

Call Options Held

970K

Put Options Held

118K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.01B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Novo Cure LTD Transaction History